<?xml version="1.0"?>
<Articles JournalTitle="Frontiers in Emergency Medicine">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Frontiers in Emergency Medicine</JournalTitle>
      <Issn>2717-3593</Issn>
      <Volume>6</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2021</Year>
        <Month>10</Month>
        <Day>19</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Renal mucormycosis following COVID-19 treatment with immune modulators: a case report</title>
    <FirstPage>e12</FirstPage>
    <LastPage>e12</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Deepak</FirstName>
        <LastName>Chaudhary</LastName>
        <affiliation locale="en_US">Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India</affiliation>
      </Author>
      <Author>
        <FirstName>Ashish</FirstName>
        <LastName>Behera</LastName>
        <affiliation locale="en_US">Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India</affiliation>
      </Author>
      <Author>
        <FirstName>Navneet</FirstName>
        <LastName>Sharma</LastName>
        <affiliation locale="en_US">Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2021</Year>
        <Month>06</Month>
        <Day>27</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2021</Year>
        <Month>08</Month>
        <Day>18</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Mucormycosis is an opportunistic fungal infection that occurs primarily in immunocompromised individuals, usually affecting the rhino-orbital areas followed by the lungs. This case report presents renal mucormycosis in a young man after COVID-19 pneumonia that escalates the need for regular follow-up of COVID-19 patients. Post-COVID-19 fungal infections are on a steep rise, and the increased use of steroids and immune modulators for COVID-19-associated immune dysregulation and cytokine syndrome increases the risk among patients treated for COVID-19.</abstract>
    <web_url>https://fem.tums.ac.ir/index.php/fem/article/view/781</web_url>
    <pdf_url>https://fem.tums.ac.ir/index.php/fem/article/download/781/371</pdf_url>
  </Article>
</Articles>
